518 related articles for article (PubMed ID: 26073984)
1. Activation and Function of iNKT and MAIT Cells.
Chandra S; Kronenberg M
Adv Immunol; 2015; 127():145-201. PubMed ID: 26073984
[TBL] [Abstract][Full Text] [Related]
2. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
Front Immunol; 2018; 9():1266. PubMed ID: 29928278
[TBL] [Abstract][Full Text] [Related]
3. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
4. iNKT cells in microbial immunity: recognition of microbial glycolipids.
Kinjo Y; Ueno K
Microbiol Immunol; 2011 Jul; 55(7):472-82. PubMed ID: 21434991
[TBL] [Abstract][Full Text] [Related]
5. Role of CD1d- and MR1-Restricted T Cells in Asthma.
Iwamura C; Nakayama T
Front Immunol; 2018; 9():1942. PubMed ID: 30210497
[TBL] [Abstract][Full Text] [Related]
6. Basic techniques for studies of iNKT cells and MAIT cells.
Chiba A; Miyake S
Methods Mol Biol; 2014; 1142():75-84. PubMed ID: 24706277
[TBL] [Abstract][Full Text] [Related]
7. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.
Cohen NR; Garg S; Brenner MB
Adv Immunol; 2009; 102():1-94. PubMed ID: 19477319
[TBL] [Abstract][Full Text] [Related]
8. Innate-like recognition of microbes by invariant natural killer T cells.
Kronenberg M; Kinjo Y
Curr Opin Immunol; 2009 Aug; 21(4):391-6. PubMed ID: 19646850
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of innate-like T lymphocytes in chronic obstructive pulmonary disease.
Szabó M; Sárosi V; Balikó Z; Bodó K; Farkas N; Berki T; Engelmann P
Respir Res; 2017 Nov; 18(1):197. PubMed ID: 29179729
[TBL] [Abstract][Full Text] [Related]
10. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
Front Immunol; 2018; 9():1990. PubMed ID: 30298063
[TBL] [Abstract][Full Text] [Related]
11. Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells.
Peterfalvi A; Gomori E; Magyarlaki T; Pal J; Banati M; Javorhazy A; Szekeres-Bartho J; Szereday L; Illes Z
Int Immunol; 2008 Dec; 20(12):1517-25. PubMed ID: 18927318
[TBL] [Abstract][Full Text] [Related]
12. The in vivo response of invariant natural killer T cells to glycolipid antigens.
Parekh VV; Lalani S; Van Kaer L
Int Rev Immunol; 2007; 26(1-2):31-48. PubMed ID: 17454263
[TBL] [Abstract][Full Text] [Related]
13. Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells.
Garner LC; Klenerman P; Provine NM
Front Immunol; 2018; 9():1478. PubMed ID: 30013556
[TBL] [Abstract][Full Text] [Related]
14. The ins and outs of type I iNKT cell development.
Shissler SC; Webb TJ
Mol Immunol; 2019 Jan; 105():116-130. PubMed ID: 30502719
[TBL] [Abstract][Full Text] [Related]
15. The autophagy machinery restrains iNKT cell activation through CD1D1 internalization.
Keller CW; Loi M; Ewert S; Quast I; Theiler R; Gannagé M; Münz C; De Libero G; Freigang S; Lünemann JD
Autophagy; 2017 Jun; 13(6):1025-1036. PubMed ID: 28296542
[TBL] [Abstract][Full Text] [Related]
16. Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults.
Lee OJ; Cho YN; Kee SJ; Kim MJ; Jin HM; Lee SJ; Park KJ; Kim TJ; Lee SS; Kwon YS; Kim N; Shin MG; Shin JH; Suh SP; Ryang DW; Park YW
Exp Gerontol; 2014 Jan; 49():47-54. PubMed ID: 24269212
[TBL] [Abstract][Full Text] [Related]
17. From the Deep Sea to Everywhere: Environmental Antigens for iNKT Cells.
Wingender G
Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):291-8. PubMed ID: 26703211
[TBL] [Abstract][Full Text] [Related]
18. Innate-like T cells in children with sickle cell disease.
Allali S; Dietrich C; Machavoine F; Rignault-Bricard R; Brousse V; de Montalembert M; Hermine O; Maciel TT; Leite-de-Moraes M
PLoS One; 2019; 14(6):e0219047. PubMed ID: 31251783
[TBL] [Abstract][Full Text] [Related]
19. Strategy of lipid recognition by invariant natural killer T cells: 'one for all and all for one'.
Mallevaey T; Selvanantham T
Immunology; 2012 Jul; 136(3):273-82. PubMed ID: 22671023
[TBL] [Abstract][Full Text] [Related]
20. CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences.
Florence WC; Bhat RK; Joyce S
Expert Rev Mol Med; 2008 Jul; 10():e20. PubMed ID: 18601810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
